IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Alkem Laboratories IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 1349.61 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. Axis Capital , Edelweiss Financial Services , J.P. Morgan India , Nomura Financial Advisory And Securities (India) are the merchant bankers of Alkem Laboratories IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 6th August 2015.
Alkem Laboratories IPO open date is 8th December 2015 and close date is 10th December 2015. IPO Allotment Date is 30th November -0001 and Listing date is 23rd December 2015.
IPO
Size:
₹ 1349.61 Cr.
Avg IPO Size (Sector Based)
: ₹
1,431.30 cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
Axis Capital
IPO by BRLM so far:
163
City:
Mumbai
IPO so far:
189
Revenue (annualised):
₹
5318.00
cr. 
PE
Ratio:
28.00x
Average Sector PE Ratio: 27.10x
Alkem Laboratories IPO size is ₹ 1349.61 Cr. with IPO price of ₹ 1050.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Axis Capital Limited is the book-running lead manager of the Alkem Laboratories IPO. Link Intime India Private Limited is the Registrar for Alkem Laboratories IPO.
Alkem Laboratories IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Alkem Laboratories IPO, based in Mumbai, operates in the Pharmaceutical sector with a focus on development manufacture and sale of pharmaceutical and neutraceutical products. The company is launching its MainBoard IPO on the BSE,NSE exchange, using the Book Building Issue method. Alkem Laboratories IPO size is ₹ 1349.61 Cr. with fresh issue size of ₹ 1,350 and Offer for sale being ₹ Nil
The IPO allotment date for Alkem Laboratories IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Alkem Laboratories IPO allotment status on the registrars website, Link Intime India Private Limited . Alkem Laboratories IPO refund dates are 30th November -0001.
Alkem Laboratories IPO is expected to be listed on 23rd December 2015.
The upper price band for the Alkem Laboratories IPO is set at ₹ 1050.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Alkem Laboratories IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Alkem Laboratories IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 10th December 2015. After submission, funds are blocked until the basis of allotment of Alkem Laboratories IPO is finalised.
The merchant banker for Alkem Laboratories IPO is Axis Capital Limited , Edelweiss Financial Services Limited , J.P. Morgan India Private Limited , Nomura Financial Advisory And Securities (India) Private Limited . Axis Capital Limited , Edelweiss Financial Services Limited , J.P. Morgan India Private Limited , Nomura Financial Advisory And Securities (India) Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Alkem Laboratories IPO RHP for further details.
The registrar for Alkem Laboratories IPO is Link Intime India Private Limited . Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Alkem Laboratories IPO through their official website or helpline.
Alkem Laboratories IPO was subscribed 44.29 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 1,349.61 Cr.
Avg IPO Size (Sector Based)
:
₹ 1,431.30 Cr.
Sector: Pharmaceutical
IPO so far:
23
Merchant Banker:
Axis Capital
IPO by BRLM so far:
163
City:
Mumbai
IPO so far:
189
Revenue (annualised):
₹ 4,119.20 cr.
PE
Ratio:
28.00x
Average Sector PE Ratio: 27.10x
Alkem Laboratories IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Alkem Laboratories Financial Review Page
Merchant Banker(s) of Alkem Laboratories IPO: Axis Capital Limited , Edelweiss Financial Services Limited , J.P. Morgan India Private Limited , Nomura Financial Advisory And Securities (India) Private Limited
Alkem Laboratories IPO subscription was 44.29 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Alkem Laboratories IPO listed at a listing price of 1381.45 against the offer price of 1050.00.
The current market price of Alkem Laboratories is 4998.50.
Why Us?
